Clinical Trial Update: Dapagliflozin in Diabetic Patients (Type 2) With Decompensated Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating dapagliflozin in type 2 diabetes patients with decompensated heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Assiut University | Conditions: Heart Failure | Phase 4 | Status: COMPLETED